Published in:
Volume 7 / Year 2018 / Issue 2

Biosimilar regulation and approval in Jordan

Author(s): , ,
Page: 77-8

Abstract: The regulatory oversight of medicinal products in Jordan is the responsibility of the Jordan Food and Drug Administration (JFDA). In 2015, JFDA adopted biosimilar guidelines, which are similar to… Read More »

Regulation of copy biologicals in China

Page: 75-6

Abstract: The first draft guidelines for copy biologicals were introduced in China back in 2014. The Technical Guideline was then updated and finalized in 2015. In this paper, how the… Read More »

Go Back Print